While the 2024 guidelines already recommended glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss due to their proven efficacy in reducing body weight and improving glycemic control, the 2025 update broadens their scope of use for their multifaceted benefits in diabetes management, including weight loss, kidney disease, and metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic-associated steatohepatitis (MASH) [11, 12]
Semaglutide and tirzepatide are both medications used for weight loss, but they have distinct differences
The compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan), with your dose able to increase as needed while your monthly price remains flatyour dose may need to go up, your price won't
Monitor for any unusual symptoms
Representatives from the Alliance for Pharmacy Compounding made similar statements to Healio in March, stating that companies that were not state-licensed compounding pharmacies were illegally selling counterfeit medications online
![Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases[v1]](https://www.preprints.org/frontend/picture/ms_xml/manuscript/fd91b5ed5a3d9b401eee39745144b181/preprints-172687-g004.png)
